Demographics (1)
- sex - Gender of participant (phv00225166.v1.p1)
Other (15)
- AFFECTION_STATUS - Case control status of the subject (phv00225161.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00225170.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00225169.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00225160.v1.p1)
- etiology - Etiology of participant (phv00225167.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00225172.v1.p1)
- IS_TUMOR - Tumor status (phv00225171.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00225173.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00225168.v1.p1)
- SAMPLE_ID - Sample ID (phv00225163.v1.p1)
- SAMPLE_USE - Sample Use (phv00225164.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00225174.v1.p1)
- SUBJECT_ID - Subject ID (phv00225159.v1.p1)
- SUBJECT_ID - Subject ID (phv00225162.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00225165.v1.p1)